NSB.AX
NeuroScientific Biopharmaceuticals Ltd
Price:  
0.05 
AUD
Volume:  
20,533.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NSB.AX Probability of Bankruptcy

The Probability of Bankruptcy of NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is -% . This number represents the probability that NSB.AX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating NSB.AX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

NSB.AX - ESG ratings

ESG ratings are directly linked to the cost of capital and NSB.AX's ability to raise funding, both of which can significantly affect the probability of NeuroScientific Biopharmaceuticals Ltd going bankrupt.

ESG Score -
Environment Score -
Social Score -
Governance Score -
Returns
Historical Returns (5 day) -7.69%
Historical Returns (MTD) -4.00%
Historical Returns (YTD) 45.45%
Historical Returns (13 week) 26.32%
Historical Returns (26 week) 33.33%
Historical Returns (52 week) -43.20%
Efficiency
Asset Turnover 0.46
Receiveable Turnover 42.61
Gross Margin
Operating Margin 49.67%
Pretax Margin 49.55%
Net Margin 49.55%
Return on Asset (ROA) 22.73
Return on Equity (ROE) 22.97
Return on Investments (ROI) 22.97
Price Metrics
Market Cap (M) 6.94
Enterprise Value (M)
52 Week High 0.07
52 Week Low 0.03
Beta 0.64
Average Volume (10 day) 0.13
Average Volume (3 month) 0.28
Price / Earnings (P/E) 5.73
Price / Sales (P/S) 2.84
Earnings
EPS 0.01
Revenue CAGR (5 year) 82.13%
Risk
Current Ratio 179.32
Quick Ratio 175.72